The Regulatory Role of MiRNAs on VDR in Breast Cancer

Overview

Journal Transcription

Specialty Molecular Biology

Date 2017 Jun 10

PMID 28598255

Citations 17

Authors

Tatyana Singh

Brian D Adams

Affiliations

Soon will be listed here.

Abstract

Triple negative breast cancer (TNBC) has been associated with the lack of three hormone receptors; estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER-2). However, a host of other steroid hormone receptors such as vitamin D receptor (VDR) is present in TNBC, and the role of these hormone receptors in breast tumorigenesis is unclear. The levels of microRNAs (miRNAs) are also expressed differently than in normal mammary epithelial cells. miRNAs are regulatory RNAs involved in various cellular functions, mainly gene silencing. Here, we reviewed the literature surrounding miRNAs in breast cancer, and performed in silico analysis to determine whether there was a correlation between levels of VDR in relation to miRNAs important in breast cancer development and tumorigenesis. We identified three miRNAs of interest, specifically, miR-23, miR-124, and miR-125. Through this research we determined the possibility that these miRNAs play an important role in controlling VDR activity and by virtue the development of breast cancer.

Citing Articles

Recent advances of miR-23 in human diseases and growth development.

Qian X, Jiang Y, Yang Y, Zhang Y, Xu N, Xu B Noncoding RNA Res. 2025; 11:220-233.

PMID: 39896346 PMC: 11787465. DOI: 10.1016/j.ncrna.2024.12.010.

sChemNET: a deep learning framework for predicting small molecules targeting microRNA function.

Galeano D, Imrat , Haltom J, Andolino C, Yousey A, Zaksas V Nat Commun. 2024; 15(1):9149.

PMID: 39443444 PMC: 11500171. DOI: 10.1038/s41467-024-49813-w.

A hypothesis: MiRNA-124 mediated regulation of sirtuin 1 and vitamin D receptor gene expression accelerates aging.

Dhar P, Moodithaya S, Patil P, Adithi K Aging Med (Milton). 2024; 7(3):320-327.

PMID: 38975301 PMC: 11222741. DOI: 10.1002/agm2.12330.

Vitamin D receptor polymorphisms and associated miRNAs in the development of breast cancer in African American women.

Aloufi A, Aubee J, Vargas K, Apprey V, Thompson K, Copeland R Gene. 2024; 927:148695.

PMID: 38945313 PMC: 11462433. DOI: 10.1016/j.gene.2024.148695.

Gene expression profiling of vitamin D metabolism enzymes in leukemia and lymphoma patients: molecular aspect interplay of VDR, CYP2R1, and CYP24A1.

Iriani A, Rachman A, Fatina M, Gemilang R, Trisnandi A, Nugraha M Mol Biol Rep. 2024; 51(1):526.

PMID: 38632160 DOI: 10.1007/s11033-024-09432-6.

References

Li Y, Chen Y, Liu W, Thadhani R . MicroRNA-mediated mechanism of vitamin D regulation of innate immune response. J Steroid Biochem Mol Biol. 2013; 144 Pt A:81-6. PMC: 3976893. DOI: 10.1016/j.jsbmb.2013.09.014. View

Singh P, van den Berg P, Long M, Vreugdenhil A, Grieshober L, Ochs-Balcom H . Integration of VDR genome wide binding and GWAS genetic variation data reveals co-occurrence of VDR and NF-κB binding that is linked to immune phenotypes. BMC Genomics. 2017; 18(1):132. PMC: 5294817. DOI: 10.1186/s12864-017-3481-4. View

Nesby-ODell S, Scanlon K, Cogswell M, Gillespie C, Hollis B, Looker A . Hypovitaminosis D prevalence and determinants among African American and white women of reproductive age: third National Health and Nutrition Examination Survey, 1988-1994. Am J Clin Nutr. 2002; 76(1):187-92. DOI: 10.1093/ajcn/76.1.187. View

Frampton R, Suva L, Eisman J, Findlay D, Moore G, Moseley J . Presence of 1,25-dihydroxyvitamin D3 receptors in established human cancer cell lines in culture. Cancer Res. 1982; 42(3):1116-9. View

Macgregor J, Jordan V . Basic guide to the mechanisms of antiestrogen action. Pharmacol Rev. 1998; 50(2):151-96. View

Mohri T, Nakajima M, Takagi S, Komagata S, Yokoi T . MicroRNA regulates human vitamin D receptor. Int J Cancer. 2009; 125(6):1328-33. DOI: 10.1002/ijc.24459. View

Friedrich M, Axt-Fliedner R, Tilgen W, Schmidt W, Reichrath J . Analysis of vitamin D-receptor (VDR) and retinoid X-receptor alpha in breast cancer. Histochem J. 2002; 34(1-2):35-40. DOI: 10.1023/a:1021343825552. View

Mendell J, Olson E . MicroRNAs in stress signaling and human disease. Cell. 2012; 148(6):1172-87. PMC: 3308137. DOI: 10.1016/j.cell.2012.02.005. View

Liu C, Calin G, Volinia S, Croce C . MicroRNA expression profiling using microarrays. Nat Protoc. 2008; 3(4):563-78. DOI: 10.1038/nprot.2008.14. View

10.

Sasaki H, Harada H, Handa Y, Morino H, Suzawa M, Shimpo E . Transcriptional activity of a fluorinated vitamin D analog on VDR-RXR-mediated gene expression. Biochemistry. 1995; 34(1):370-7. DOI: 10.1021/bi00001a045. View

11.

Wejse C, Olesen R, Rabna P, Kaestel P, Gustafson P, Aaby P . Serum 25-hydroxyvitamin D in a West African population of tuberculosis patients and unmatched healthy controls. Am J Clin Nutr. 2007; 86(5):1376-83. DOI: 10.1093/ajcn/86.5.1376. View

12.

Thakkar A, Wang B, Picon-Ruiz M, Buchwald P, Ince T . Vitamin D and androgen receptor-targeted therapy for triple-negative breast cancer. Breast Cancer Res Treat. 2016; 157(1):77-90. PMC: 4869778. DOI: 10.1007/s10549-016-3807-y. View

13.

Aguilera O, Pena C, Garcia J, Larriba M, Ordonez-Moran P, Navarro D . The Wnt antagonist DICKKOPF-1 gene is induced by 1alpha,25-dihydroxyvitamin D3 associated to the differentiation of human colon cancer cells. Carcinogenesis. 2007; 28(9):1877-84. DOI: 10.1093/carcin/bgm094. View

14.

Long M, Sucheston-Campbell L, Campbell M . Vitamin D receptor and RXR in the post-genomic era. J Cell Physiol. 2014; 230(4):758-66. PMC: 4574486. DOI: 10.1002/jcp.24847. View

15.

Lehmann B, Bauer J, Chen X, Sanders M, Chakravarthy A, Shyr Y . Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies. J Clin Invest. 2011; 121(7):2750-67. PMC: 3127435. DOI: 10.1172/JCI45014. View

16.

Lappe J, Travers-Gustafson D, Davies K, Recker R, Heaney R . Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am J Clin Nutr. 2007; 85(6):1586-91. DOI: 10.1093/ajcn/85.6.1586. View

17.

Kretschmann K, Eyob H, Buys S, Welm A . The macrophage stimulating protein/Ron pathway as a potential therapeutic target to impede multiple mechanisms involved in breast cancer progression. Curr Drug Targets. 2010; 11(9):1157-68. DOI: 10.2174/138945010792006825. View

18.

Prufer K, Barsony J . Retinoid X receptor dominates the nuclear import and export of the unliganded vitamin D receptor. Mol Endocrinol. 2002; 16(8):1738-51. DOI: 10.1210/me.2001-0345. View

19.

Fire A, Xu S, Montgomery M, Kostas S, Driver S, Mello C . Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature. 1998; 391(6669):806-11. DOI: 10.1038/35888. View

20.

Alimirah F, Vaishnav A, McCormick M, Echchgadda I, Chatterjee B, Mehta R . Functionality of unliganded VDR in breast cancer cells: repressive action on CYP24 basal transcription. Mol Cell Biochem. 2010; 342(1-2):143-50. PMC: 2923673. DOI: 10.1007/s11010-010-0478-6. View